title: Adherence of neutrophils to hemodialysis membranes: role of complement receptors.
abstract: Complement activation occurs during hemodialysis using cellulosic dialysis membranes with the consequent deposition of C3 activation and degradation products on the membrane surface. To determine if these complement fragments are functionally active, we examined their capacity to mediate leukocyte adherence to cuprophan membranes. Immunoblotting of proteins eluted from plasma-treated cuprophan membranes confirmed the presence of both C3b and iC3b. Incubation of cuprophan membranes with heparinized whole blood resulted in adherence of leukocytes but not erythrocytes. Neutrophils were the primary cell type bound, with monocytes comprising less than 5% of the adherent cells. Studies using indium-labeled neutrophils demonstrated that the binding was plasma dependent and increased with time up to two hours. Neutrophil binding was inhibited by preincubation of the plasma-treated cuprophan membrane with anti-C3 or preincubation of neutrophils with an antibody directed against the alpha chain of complement receptor type 3 (CR3). These observations indicate that iC3b deposited on cuprophan membrane surface as a result of complement activation mediates neutrophil adherence via interaction with CR3. They also support the hypothesis that, in addition to the anaphylatoxins released into the fluid phase, complement activation products that remained membrane bound during hemodialysis also stimulate pathophysiological responses.
authors.affiliation: Renal Section, Veterans Affairs Medical Center, Salt Lake City, Utah.
authors.forename: A K
authors.initials: AK
authors.lastname: Cheung
authors.forename: M
authors.initials: M
authors.lastname: Hohnholt
authors.forename: J
authors.initials: J
authors.lastname: Gilson
mesh_terms: D002448:Cell Adhesion; D002482:Cellulose / Q000031:analogs & derivatives; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D066298:In Vitro Techniques; D007688:Kidneys, Artificial; D008567:Membranes, Artificial; D008855:Microscopy, Electron, Scanning; D009504:Neutrophils / Q000166:cytology* / Q000276:immunology*; D011951:Receptors, Complement / Q000378:metabolism*; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D003176:Complement C3; D007074:Immunoglobulin G; D008567:Membranes, Artificial; D011951:Receptors, Complement; D002482:Cellulose; C009865:cuprammonium cellulose